fat-7 Antibody

What is fat-7 and why is it important in research applications?

Fat-7 is a stearoyl-CoA desaturase (SCD1 homolog) in C. elegans that serves as a critical gatekeeper of polyunsaturated fatty acid (PUFA) biosynthesis by converting stearoyl-CoA into oleoyl-CoA. Unlike its paralog FAT-6, fat-7 plays a particularly important role in maintaining membrane fluidity during thermal stress conditions, making it a valuable target for studying lipid metabolism regulation . The expression of fat-7 is strongly induced by as little as 3 hours of cold exposure and conversely suppressed during heat exposure, indicating its central role in temperature adaptation mechanisms .

Fat-7 antibodies allow researchers to track protein expression and localization patterns across different experimental conditions, providing insights beyond what gene expression studies alone can offer. This is particularly valuable given that post-transcriptional regulation may result in discrepancies between mRNA and protein levels. The ability to directly visualize and quantify fat-7 protein through antibody-based techniques enables more comprehensive characterization of lipid metabolism pathways in response to environmental stimuli, genetic manipulations, or disease models.

Research involving fat-7 antibodies has implications for broader understanding of metabolic regulation, as the mechanisms governing fatty acid desaturation are evolutionarily conserved across many species, including mammalian systems where the homologous SCD1 plays similar roles in lipid homeostasis.

How does fat-7 differ from other desaturases and what implications does this have for antibody specificity?

In C. elegans, the genome encodes multiple stearoyl-CoA desaturases, with fat-6 and fat-7 being the primary Δ9 desaturases functionally analogous to mammalian SCD1 . While these enzymes share structural similarities, they exhibit distinct expression patterns and regulatory responses. Fat-7, unlike fat-6, is strongly regulated by thermal conditions and plays a more prominent role in temperature adaptation mechanisms . This functional specialization suggests structural or regulatory differences that researchers must consider when developing and utilizing antibodies.

The structural similarity between fat-7 and other desaturases presents a significant challenge for antibody specificity. Researchers must carefully validate antibodies to ensure they recognize fat-7 without cross-reacting with fat-6 or other related proteins. Similar challenges have been documented with other antibodies targeting related protein families, as seen with Factor VII antibodies that can detect distinct forms of the protein with varying molecular weights . Validation strategies should include Western blotting against tissues from knockout models, comparative analysis with tissues expressing different desaturase levels, and specificity testing against recombinant proteins where available.

For studies comparing fat-7 with mammalian SCD1, researchers should consider using separate validated antibodies rather than assuming cross-reactivity, as even conserved proteins can have significant epitope differences across evolutionary distances. This approach is supported by techniques seen in other cross-species antibody applications, where careful validation is essential for accurate interpretation .

What regulatory pathways control fat-7 expression and how can antibodies help elucidate these mechanisms?

Fat-7 expression is primarily regulated via the nuclear receptor NHR-49, which is a homolog of human hepatocyte nuclear factor-4α (HNF4α) but functionally resembles PPARα . The regulation involves complex interactions with multiple metabolic pathways, including those influenced by microbiota and thermal stress adaptation. The acyl-CoA dehydrogenase ACDH-11 plays a central role in attenuating NHR-49-dependent expression of fat-7 during heat adaptation, while cold exposure induces fat-7 expression .

Antibodies against fat-7 provide a valuable tool for studying these regulatory networks by allowing researchers to:

• Track protein expression changes in response to various stimuli, including temperature shifts, dietary interventions, and exposure to microbial metabolites

• Determine whether post-transcriptional regulation modifies the relationship between mRNA expression and protein abundance

• Visualize subcellular localization patterns that may change under different regulatory conditions

• Identify protein-protein interactions through co-immunoprecipitation experiments

Recent research has revealed that both endogenous and microbiota-dependent small molecule signals can promote lipid desaturation via NHR-49/PPARα in C. elegans . Specifically, a β-cyclopropyl fatty acid (becyp#1) produced by associated bacteria and a β-methyl fatty acid (bemeth#1) derived from the host organism both activate fat-7 expression. Antibody-based approaches can help quantify how these metabolites affect fat-7 protein levels, potentially revealing disconnects between transcriptional and translational responses.

How can fat-7 antibodies be integrated into studies of host-microbiome interactions?

Recent discoveries have revealed a fascinating interplay between microbial metabolites and host lipid desaturation pathways involving fat-7. Specifically, the β-cyclopropyl fatty acid (becyp#1) produced by bacteria such as E. coli can potently activate fat-7 expression through NHR-49 . This presents a valuable opportunity to use fat-7 antibodies to explore the interface between microbiome composition and host metabolism.

Researchers can employ fat-7 antibodies in gnotobiotic studies where C. elegans are exposed to defined bacterial strains or communities. Western blotting and immunohistochemistry can quantify fat-7 protein levels and localization patterns in response to different microbial exposures. This approach could reveal how specific bacterial species or their metabolites influence host lipid metabolism at the protein level, potentially identifying discrepancies between transcriptional and translational responses. The techniques would be similar to those used for detecting other proteins in tissues, such as the methodologies described for Factor VII detection in human tissues .

For more sophisticated analyses, researchers could combine fat-7 antibody-based detection with metabolomic profiling to correlate specific bacterial metabolites with fat-7 protein expression. This multi-omics approach would provide insights into how the microbiome shapes host lipid homeostasis through fat-7 regulation. Additionally, co-immunoprecipitation experiments using fat-7 antibodies could identify protein interaction partners that may be modified by microbial signals, further elucidating the molecular mechanisms of host-microbe metabolic crosstalk.

What are the considerations for using fat-7 antibodies in comparative studies across different model organisms?

Epitope conservation is the primary concern for cross-species antibody applications. Even with high sequence homology in the functional domains of desaturases, antibody binding regions may differ significantly. Researchers should thoroughly validate antibody cross-reactivity against the target protein in each species of interest. This validation could follow approaches similar to those used for other antibodies, such as the FAT1 antibody described in search result , where species cross-reactivity is carefully documented based on sequence homology and experimental verification.

The table below outlines recommended validation approaches for cross-species fat-7 antibody applications:

When interpreting results from cross-species studies, researchers should also consider differences in post-translational modifications, subcellular localization patterns, and tissue-specific expression profiles of fat-7 homologs. These factors may influence antibody binding efficiency and the biological interpretation of observed signals. Supplementing antibody-based detection with genetic approaches and functional assays will provide more comprehensive and reliable comparative analyses across model organisms.

How can researchers use fat-7 antibodies to investigate the relationship between thermal stress and lipid metabolism?

Given that fat-7 expression is strongly regulated by temperature conditions, with induction during cold exposure and suppression during heat exposure , fat-7 antibodies offer a valuable tool for investigating thermally-responsive lipid metabolism pathways. This application is particularly important considering fat-7's role in maintaining membrane fluidity during thermal stress.

Researchers can design time-course experiments exposing C. elegans to different temperature regimes, followed by protein extraction and Western blotting with fat-7 antibodies to quantify changes in protein expression. Immunohistochemistry would complement these analyses by revealing potential changes in subcellular localization or tissue distribution patterns under thermal stress. The protocols would be similar to those employed for other antibodies, such as the immersion fixation and fluorescent detection methods described for Factor VII antibody .

For more mechanistic insights, researchers could use fat-7 antibodies in conjunction with antibodies against regulatory proteins such as NHR-49 and ACDH-11. Co-immunoprecipitation experiments could reveal temperature-dependent changes in protein-protein interactions that may influence fat-7 activity. Additionally, chromatin immunoprecipitation (ChIP) using antibodies against transcription factors followed by qPCR of the fat-7 promoter region could elucidate how thermal stress modulates transcriptional regulation of fat-7.

A comprehensive experimental design would include:

• Temperature gradient studies (15°C to 25°C) with protein analysis at multiple time points

• Comparison of wild-type and acdh-11 mutant responses using fat-7 antibodies

• Correlation of fat-7 protein levels with membrane lipid composition analysis

• Visualization of fat-7 localization changes during acute and chronic temperature shifts

This approach would provide unprecedented insights into how organisms adapt their lipid metabolism to environmental temperature fluctuations through regulated changes in desaturase expression and activity.

What are the optimal sample preparation protocols for fat-7 antibody applications in Western blotting?

Effective sample preparation is crucial for successful detection of fat-7 protein using antibody-based Western blotting. Due to the membrane-associated nature of desaturases like fat-7, special considerations are necessary to ensure efficient protein extraction and preservation of epitope integrity.

For C. elegans samples, researchers should begin with synchronized worm populations to minimize developmental variation in fat-7 expression. Flash-freezing worms in liquid nitrogen followed by homogenization using a bead beater in a buffer containing 1% NP-40 or Triton X-100, 150 mM NaCl, 50 mM Tris-HCl (pH 7.5), and protease inhibitor cocktail is recommended. For mammalian cells expressing SCD1 (the fat-7 homolog), similar detergent-based extraction buffers are appropriate, though the addition of 0.1% SDS may improve solubilization of the membrane-bound protein.

When preparing protein samples for SDS-PAGE, researchers should avoid excessive heating, which can cause aggregation of membrane proteins like fat-7. Incubation at 37°C for 30 minutes in Laemmli buffer is preferable to boiling. Additionally, the use of reducing conditions is critical, as seen with other antibody applications like the Human Coagulation Factor VII antibody, which was specifically tested under reducing conditions . For fat-7, a similar approach with 5% β-mercaptoethanol is recommended.

The expected molecular weight of fat-7 protein should be approximately 37-41 kDa, though this may vary slightly based on post-translational modifications. Researchers should include appropriate positive controls (such as extracts from wild-type animals known to express fat-7) and negative controls (such as extracts from fat-7 mutants) to validate antibody specificity. For improved detection of low-abundance proteins, methods like enhanced chemiluminescence or fluorescent secondary antibodies are recommended, similar to the HRP-conjugated or NorthernLights™ 557-conjugated secondary antibodies used for Factor VII detection .

What are the recommended protocols for immunohistochemical detection of fat-7?

Immunohistochemical detection of fat-7 requires careful attention to fixation, permeabilization, and antibody incubation conditions to preserve protein localization while ensuring antibody accessibility to this membrane-associated protein. Based on protocols used for similar proteins, the following methodology is recommended:

For C. elegans whole-mount preparations, animals should be fixed using 4% paraformaldehyde in PBS for 30 minutes at room temperature, followed by permeabilization with 0.1% Triton X-100 for 30-60 minutes. When working with mammalian cells expressing SCD1 (the fat-7 homolog), researchers can adapt protocols similar to those used for Factor VII detection in human PBMCs, which utilized immersion fixation followed by staining with primary antibody at 10-15 μg/mL for 3 hours at room temperature .

Blocking with 5% BSA or normal serum (matching the species of the secondary antibody) for 1 hour at room temperature will minimize non-specific binding. Primary antibody incubation should be performed overnight at 4°C at dilutions ranging from 1:100 to 1:500, depending on antibody affinity. Secondary antibody detection can utilize fluorescent conjugates, similar to the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody used for Factor VII detection , with DAPI counterstaining to visualize nuclei.

For more sophisticated co-localization studies, researchers can simultaneously probe for fat-7 and organelle markers (such as ER or Golgi markers) using differently labeled secondary antibodies. This approach would provide insights into the subcellular localization and trafficking of fat-7 under different experimental conditions. Additionally, for studies in larger organisms, tissue sections should be processed using standard histological techniques, with antigen retrieval steps (such as citrate buffer treatment at 95°C for 20 minutes) potentially necessary to expose epitopes masked during fixation.

As with all immunohistochemical applications, careful validation through appropriate controls is essential, including omission of primary antibody, use of pre-immune serum, and comparison with tissues known to be negative for fat-7 expression.

How should researchers validate the specificity of fat-7 antibodies?

Rigorous validation of antibody specificity is essential for generating reliable and reproducible results with fat-7 antibodies. This is particularly important given the structural similarity between fat-7 and other desaturases like fat-6 in C. elegans or SCD isoforms in mammals. A comprehensive validation strategy should include multiple complementary approaches.

Western blot validation should include positive controls (tissues known to express fat-7), negative controls (fat-7 knockout/knockdown samples), and specificity controls (recombinant fat-7 protein). The detection of a single band at the expected molecular weight (~37-41 kDa) would support antibody specificity. Similar validation approaches have been used for other antibodies, such as the FAT1 antibody described in search result , where specificity was carefully documented based on reactivity patterns.

For genetic validation, researchers should compare antibody signals between wild-type animals and fat-7 mutants or RNAi-treated samples. A significant reduction or complete loss of signal in the mutant/knockdown samples would confirm specificity. Additionally, overexpression models can be used to further validate antibody performance, as increased signal intensity should correlate with elevated fat-7 expression levels.

The table below summarizes recommended validation experiments for fat-7 antibodies:

Researchers should be aware that environmental conditions can significantly affect fat-7 expression levels. For instance, temperature changes known to regulate fat-7 should be carefully controlled during validation experiments to avoid misinterpreting expression differences as antibody specificity issues.

How can researchers address discrepancies between fat-7 mRNA and protein expression levels?

Discrepancies between mRNA and protein levels for fat-7 are not uncommon and can provide valuable insights into post-transcriptional regulatory mechanisms. When researchers observe such discrepancies, several analytical approaches can help elucidate the underlying mechanisms and ensure accurate interpretation of results.

Time-course experiments are particularly valuable, as mRNA and protein expression changes may be temporally offset. For example, while fat-7 mRNA is reported to be strongly induced after as little as 3 hours of cold exposure , protein accumulation may lag behind due to translation time and protein folding processes. Researchers should collect samples at multiple time points (e.g., 0, 3, 6, 12, 24 hours) after experimental intervention, measuring both mRNA (via qPCR) and protein (via Western blotting with fat-7 antibodies) to establish temporal relationships.

Post-translational regulatory mechanisms should also be investigated when discrepancies are observed. Protein stability can be assessed through cycloheximide chase experiments, where protein synthesis is blocked and fat-7 protein degradation is monitored over time using antibody detection. Additionally, researchers can explore whether fat-7 undergoes post-translational modifications that might affect antibody recognition, protein stability, or enzymatic activity.

Another consideration is the potential existence of alternative fat-7 isoforms or processing variants. In research with Factor VII, for instance, a previously undescribed form called VII* was detected that had a molecular weight 4,500 D less than the main Factor VII and lacked detectable functional activity . Researchers should be alert to unexpected band patterns in Western blots that might indicate similar processing of fat-7, potentially comparing detection patterns using antibodies targeting different epitopes.

Finally, tissue-specific or subcellular compartmentalization effects may contribute to apparent discrepancies. Immunohistochemistry using fat-7 antibodies can reveal whether protein distribution patterns change under experimental conditions in ways not reflected by total protein measurements.

What controls are necessary when studying fat-7 in temperature adaptation experiments?

Given fat-7's established role in thermal adaptation through its regulation of membrane fluidity, temperature-focused experiments require particularly rigorous controls to ensure valid interpretation of antibody-based results. The temperature-sensitive nature of fat-7 expression, with induction during cold exposure and suppression during heat exposure , necessitates a structured experimental approach.

Temperature calibration and stability are paramount. Researchers should use calibrated thermometers or temperature loggers to verify that incubators, water baths, or environmental chambers maintain consistent temperatures throughout experiments. Temperature ramp rates should be standardized, as gradual versus rapid temperature changes may elicit different regulatory responses in fat-7 expression.

The experimental timeline must include appropriate temperature acclimation periods. C. elegans typically requires 3-6 hours to show significant changes in fat-7 expression after temperature shifts . Short-term fluctuations should be avoided, and researchers should document the precise temperature history of experimental samples. Control samples maintained at standard culture temperature (typically 20°C for C. elegans) should be processed identically and simultaneously with experimental samples.

When analyzing fat-7 protein levels using antibodies, researchers should include controls for temperature effects on general protein expression, stability, and extraction efficiency. This can be accomplished by quantifying housekeeping proteins that are not temperature-regulated or by using total protein staining methods like Ponceau S. Additionally, researchers should monitor the expression of NHR-49 and ACDH-11, which are known regulators of fat-7 during thermal adaptation , to provide context for interpreting fat-7 antibody results.

For genetic validation, temperature experiments should include fat-7 mutant animals as negative controls and potentially acdh-11 mutants (which exhibit constitutively high fat-7 expression ) as positive controls. This genetic framework helps distinguish temperature-specific effects from other experimental variables that might influence fat-7 detection.

How should researchers interpret contradictory results between different detection methods for fat-7?

When faced with contradictory results between different methods of detecting fat-7 (such as discrepancies between Western blotting, immunohistochemistry, or functional assays), researchers should systematically investigate potential methodological, biological, and technical factors that might explain these differences.

Antibody-specific factors are a primary consideration. Different antibodies targeting distinct epitopes of fat-7 may yield varying results if these epitopes are differentially accessible under certain conditions or affected by post-translational modifications. This phenomenon has been observed with other proteins like Factor VII, where specific monoclonal antibodies recognize different forms of the protein . Researchers should compare results using multiple validated antibodies targeting different regions of fat-7 when possible.

Sample preparation differences can significantly impact detection outcomes. Membrane proteins like fat-7 are particularly sensitive to extraction conditions, and variations in detergent types or concentrations may affect solubilization efficiency. When Western blotting and immunohistochemistry yield contradictory results, researchers should consider whether fixation conditions for immunohistochemistry might alter epitope accessibility or whether extraction buffers for Western blotting might differentially solubilize certain protein pools.

The table below outlines a structured approach to troubleshooting contradictory fat-7 detection results:

Biological variables may also explain apparent contradictions. Fat-7 expression exhibits tissue specificity and is responsive to numerous environmental factors beyond temperature, including dietary conditions and microbial exposures . Researchers should carefully document and control these variables, potentially using tissue-specific approaches like laser capture microdissection followed by targeted protein analysis.

When contradictions persist despite methodological optimization, researchers should consider the possibility of novel regulatory mechanisms affecting fat-7. For instance, the discovery that both endogenous and microbiota-dependent small molecule signals can influence fat-7 expression highlights the complex regulatory network governing this protein's expression and function.

How can fat-7 antibodies contribute to understanding the evolutionary conservation of lipid metabolism pathways?

The evolutionary conservation of fatty acid desaturation mechanisms makes fat-7 antibodies valuable tools for comparative studies across species. The fat-7 gene in C. elegans represents an evolutionary counterpart to mammalian SCD1, with both playing crucial roles in converting saturated fatty acids to monounsaturated forms . By developing antibodies that can detect conserved epitopes across species or species-specific antibodies for comparative analysis, researchers can trace the evolutionary trajectory of desaturase function and regulation.

Comparative immunohistochemistry studies using fat-7/SCD1 antibodies could reveal conserved and divergent patterns of desaturase localization across evolutionary lineages. Such studies would provide insights into how subcellular organization of lipid metabolism pathways has evolved. Similarly, protein interaction studies using co-immunoprecipitation with fat-7 antibodies could identify whether regulatory protein networks are conserved between nematodes and mammals, potentially revealing how the NHR-49 regulatory mechanism in C. elegans relates to PPARα-mediated regulation in mammals.

Particularly intriguing is the potential to use fat-7 antibodies to investigate the evolution of thermal adaptation mechanisms. Given fat-7's established role in cold-induced membrane fluidity regulation in C. elegans , comparative studies could reveal whether homologous desaturases in other species respond similarly to temperature fluctuations. This has implications for understanding how different organisms adapt to their thermal environments through lipid metabolism adjustments.

The search results reveal a fascinating evolutionary connection where a methyltransferase (fcmt-1) that influences fat-7 expression in C. elegans likely originated from bacterial cyclopropane synthase via ancient horizontal gene transfer . Antibody-based studies could help trace this evolutionary relationship by comparing protein expression patterns and modifications between bacterial and nematode systems, potentially revealing how ancient gene transfer events have shaped modern lipid metabolism pathways.

What potential exists for using fat-7 antibodies in human metabolic disease research?

While fat-7 is a C. elegans protein, the high degree of conservation in fatty acid desaturation pathways suggests that research using fat-7 antibodies could provide translatable insights for human metabolic disease studies. The mammalian homolog, SCD1, has been implicated in various metabolic disorders, including obesity, diabetes, and non-alcoholic fatty liver disease.

C. elegans offers advantages as a model organism for initial screening and mechanistic studies of metabolic pathways. By using fat-7 antibodies to characterize how different genetic backgrounds, environmental conditions, or pharmacological interventions affect desaturase expression and function in worms, researchers can identify promising targets for subsequent validation in mammalian systems. The discovery that both microbial and host-derived molecules regulate fat-7 expression parallels emerging research on microbiome influences on human metabolic health.

One particularly promising application involves screening potential therapeutic compounds that modulate desaturase activity. Researchers could use fat-7 antibodies to quantify how candidate compounds affect protein expression in C. elegans, potentially identifying molecules that normalize desaturase levels under pathological conditions. This approach could be especially valuable for investigating conditions where SCD1 dysregulation contributes to disease pathogenesis, such as insulin resistance or hepatic steatosis.

Additionally, the regulation of fat-7 by NHR-49, which functionally mimics PPARα despite being structurally related to HNF4α , suggests evolutionary plasticity in nuclear receptor function. This has implications for understanding the flexibility and constraints in nuclear receptor-mediated regulation of metabolism across species. Antibody-based studies comparing fat-7/NHR-49 interactions in C. elegans with SCD1/PPARα interactions in mammals could reveal conserved regulatory mechanisms that might be targeted therapeutically.

It's worth noting that research on fatty acid binding proteins (another class of lipid metabolism regulators) has already demonstrated relevance to human liver diseases such as hepatitis and liver cancer . Similar translational potential likely exists for insights gained from studying fat-7 regulation in model organisms.

How might fat-7 antibodies contribute to our understanding of lipid-mediated immune responses?

Recent research has revealed unexpected connections between fatty acid metabolism and immune function, suggesting novel applications for fat-7 antibodies in immunometabolism studies. The search results indicate that high levels of serum long chain saturated fatty acids have been associated with inflammation in type 2 diabetes, and that IgG antibodies recognizing nonesterified saturated fatty acids are present in human blood . This raises intriguing questions about how fatty acid desaturases like fat-7 might influence immune responses through modification of fatty acid profiles.

Researchers could use fat-7 antibodies to investigate how changes in desaturase expression affect membrane lipid composition in immune cells, potentially altering their function and inflammatory responses. In C. elegans, which lacks an adaptive immune system but possesses innate immune mechanisms, fat-7 antibodies could help elucidate connections between lipid desaturation and pathogen resistance. The observation that microbial metabolites regulate fat-7 expression suggests a potential feedback loop wherein microbe-host interactions influence lipid metabolism, which in turn may modify immune responses.

Comparative studies between wild-type and fat-7 mutant C. elegans exposed to pathogens could reveal whether desaturase activity influences survival or innate immune activation. Antibody-based detection of fat-7 protein levels and localization in these experiments would provide mechanistic insights into how lipid metabolism changes during immune challenges. These findings could then be extended to mammalian systems to explore whether SCD1 plays similar roles in immune cell function.

The discovery that antibodies against long chain saturated fatty acids exist in human serum and may be relevant to diabetes pathogenesis suggests another fascinating application: researchers could investigate whether fat-7/SCD1 activity influences the production of these autoantibodies by altering the availability of saturated fatty acid antigens. This could establish a novel link between desaturase function and autoimmune aspects of metabolic diseases.